To access this element change to forms mode OFF
Grant Award View - GA217913
REDEEM: A Randomised Controlled Trial of ECMO to Desedate, Extubate...
GA ID:
GA217913
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$2,534,432.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
REDEEM: A Randomised Controlled Trial of ECMO to Desedate, Extubate Early and Mobilise in severe acute respiratory infection
Purpose:
The EVEREST trial is an Australian-initiated, registry-based, multicentre, randomised controlled trial to determine if early ECMO (with desedation, early extubation, and mobilisation), in comparison to standard care (including continuing mechanical ventilation), improves key patient centred outcomes, and reduces health care costs. The EVEREST trial is a pivotal study that will guide the treatment of respiratory failure globally - for COVID-19, as well as for future pandemics.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2015039
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA, QLD
Postcode:
Multiple
Country:
AUSTRALIA